Tuesday, August 19, 2025 | ROI-NJ
Osteogene Tech Corp., a commercial-stage bone regenerative business, said Aug. 19 that it was selected as one of the early-stage technology companies to receive up to $1 million in matching funding from the New Jersey Economic Development Authority’s Angel Match Program.
To view the full article, please visit ROI-NJ: https://www.roi-nj.com/2025/08/19/healthcare/osteogene-to-receive-up-to-1m-in-matching-funding-from-njeda-to-boost-rollout-of-therapy/